SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 170.49 |
| Enterprise Value ($M) | 164.66 |
| Book Value ($M) | 4.98 |
| Book Value / Share | 0.38 |
| Price / Book | 34.22 |
| NCAV ($M) | 4.98 |
| NCAV / Share | 0.38 |
| Price / NCAV | 34.23 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.11 |
| Return on Assets (ROA) | -1.15 |
| Return on Equity (ROE) | -1.19 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.91 |
| Current Ratio | 6.91 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 5.82 |
| Assets | 5.83 |
| Liabilities | 0.84 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 10,412 | 25,922 | 40.17 | |
| 11,841 | 36,040 | 32.86 | |
| 8,661 | 28,887 | 29.98 | |
| 11,173 | 24,944 | 44.79 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GDTC – CytoMed Therapeutics Limited | GELS – Gelteq Limited |
| GLMD – Galmed Pharmaceuticals Ltd. | GLTO – Galecto, Inc. |
| GNLX – Genelux Corporation |
Financial data and stock pages provided by
Fintel.io